Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
aldesleukin (Proleukin) (1 trial)
sorafenib (nexavar) (1 trial)
Carcinoma (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Neoplasm Metastasis (Phase 2)
Trials (1 total)
Trial APIs (2 total)